Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

Trimera mouse model for human HBV described

Feb. 23, 1999

Xenometrix grants gene expression profiling patent license to Genzyme

Feb. 23, 1999

U.S. patent providing improved gene delivery vectors issued to GenVec

Feb. 22, 1999

Incyte and ICAgen collaborate on ion channel R&D

Feb. 19, 1999

Inhale branches out into pulmonary controlled release

Feb. 18, 1999

Proteomics research grant awarded to Kinetek

Feb. 18, 1999

Apotex extends agreement with Cangene

Feb. 18, 1999

Ares-Serono signs agreement with PowderJect for drug delivery system

Feb. 18, 1999

Scios signs drug screening and license agreement with Telik

Feb. 18, 1999

Aastrom cord blood therapy kit receives CE Mark approval

Feb. 17, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 9, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...